JP2005502675A - 喘息治療用の製薬組成物 - Google Patents

喘息治療用の製薬組成物 Download PDF

Info

Publication number
JP2005502675A
JP2005502675A JP2003524562A JP2003524562A JP2005502675A JP 2005502675 A JP2005502675 A JP 2005502675A JP 2003524562 A JP2003524562 A JP 2003524562A JP 2003524562 A JP2003524562 A JP 2003524562A JP 2005502675 A JP2005502675 A JP 2005502675A
Authority
JP
Japan
Prior art keywords
mometasone furoate
formoterol fumarate
metered dose
dose inhaler
aerosol suspension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003524562A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005502675A5 (enExample
Inventor
ジョエル エー． セクエイラ，
ステファン エー． シャープ，
ジョン エル． ハート，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp & Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23224164&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP2005502675(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of JP2005502675A publication Critical patent/JP2005502675A/ja
Publication of JP2005502675A5 publication Critical patent/JP2005502675A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2003524562A 2001-08-28 2002-08-27 喘息治療用の製薬組成物 Pending JP2005502675A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31538601P 2001-08-28 2001-08-28
PCT/US2002/027336 WO2003020253A2 (en) 2001-08-28 2002-08-27 Pharmaceutical compositions for the treatment of asthma

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2009126933A Division JP2009185075A (ja) 2001-08-28 2009-05-26 喘息治療用の製薬組成物
JP2010036706A Division JP5170789B2 (ja) 2001-08-28 2010-02-22 喘息治療用の製薬組成物

Publications (2)

Publication Number Publication Date
JP2005502675A true JP2005502675A (ja) 2005-01-27
JP2005502675A5 JP2005502675A5 (enExample) 2006-01-05

Family

ID=23224164

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2003524562A Pending JP2005502675A (ja) 2001-08-28 2002-08-27 喘息治療用の製薬組成物
JP2009126933A Pending JP2009185075A (ja) 2001-08-28 2009-05-26 喘息治療用の製薬組成物
JP2010036706A Expired - Fee Related JP5170789B2 (ja) 2001-08-28 2010-02-22 喘息治療用の製薬組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2009126933A Pending JP2009185075A (ja) 2001-08-28 2009-05-26 喘息治療用の製薬組成物
JP2010036706A Expired - Fee Related JP5170789B2 (ja) 2001-08-28 2010-02-22 喘息治療用の製薬組成物

Country Status (26)

Country Link
US (3) US20030114428A1 (enExample)
EP (3) EP2092935B1 (enExample)
JP (3) JP2005502675A (enExample)
KR (1) KR100970531B1 (enExample)
CN (2) CN1649568B (enExample)
AR (1) AR036358A1 (enExample)
AT (2) ATE430555T1 (enExample)
AU (1) AU2002313828B2 (enExample)
BR (1) BR0212089A (enExample)
CA (1) CA2457926A1 (enExample)
CO (1) CO5560551A2 (enExample)
CY (2) CY1109212T1 (enExample)
DE (2) DE60239648D1 (enExample)
DK (2) DK2092935T3 (enExample)
ES (3) ES2389480T3 (enExample)
HU (1) HUP0401514A3 (enExample)
MX (1) MXPA04001875A (enExample)
NO (1) NO20041277L (enExample)
NZ (1) NZ530987A (enExample)
PE (1) PE20030390A1 (enExample)
PL (1) PL209640B1 (enExample)
PT (2) PT1420759E (enExample)
SI (2) SI1420759T1 (enExample)
TW (1) TWI324934B (enExample)
WO (1) WO2003020253A2 (enExample)
ZA (1) ZA200401419B (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005536538A (ja) * 2002-08-23 2005-12-02 シェーリング　コーポレイション 薬学的組成物
JP2010518076A (ja) * 2007-02-09 2010-05-27 シェーリング コーポレイション 安定な医薬エアロゾル製剤
JP2019503997A (ja) * 2015-12-04 2019-02-14 メキシケム フロー エセ・ア・デ・セ・ヴェ 薬学的組成物

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9904919D0 (en) * 1999-03-03 1999-04-28 Novartis Ag Organic compounds
CN100496608C (zh) * 2001-03-30 2009-06-10 洁垢技术有限公司 药用气溶胶制剂
GB0207906D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
EP1785156B1 (en) * 2002-08-23 2012-06-27 Schering Corporation Metered dose inhaler containing an aerosol suspension formulation
SI1542904T1 (sl) * 2002-08-27 2008-06-30 Schering Corp Postopek za izdelavo inhalacijskih formulacij z merjenim odmerkom
GB0323684D0 (en) 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
GB0323685D0 (en) * 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
JP2007509147A (ja) * 2003-10-20 2007-04-12 シェーリング　コーポレイション 薬学的エアロゾル組成物
EP1925293A3 (en) * 2003-10-20 2010-01-13 Schering Corporation Pharmaceutical aerosol compositions
ES2340777T3 (es) * 2004-01-21 2010-06-09 Schering Corporation Metodo de tratamiento de la rinosinusitis aguda.
US20110053999A1 (en) * 2004-03-03 2011-03-03 Daley Thomas E 4-methylpyrazole formulations for inhibiting ethanol intolerance
WO2006040598A2 (en) * 2004-10-12 2006-04-20 Generics (Uk) Limited Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister
EP2484382A1 (en) 2005-03-30 2012-08-08 Schering Corporation Medicament comprising a phosphodiesterase IV inhibitor in an inhalable form
CA2641616A1 (en) * 2006-02-09 2007-08-23 Schering Corporation Pharmaceutical formulations
US20080253970A1 (en) * 2007-02-09 2008-10-16 Schering Corporation Stable Pharmaceutical Drug Products
GB0714239D0 (en) * 2007-07-20 2007-08-29 Glaxo Group Ltd Method
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
WO2009089422A2 (en) * 2008-01-10 2009-07-16 Schering Corporation Inhalation drug products, systems and uses
GB0801876D0 (en) 2008-02-01 2008-03-12 Vectura Group Plc Suspension formulations
EP2414560B1 (de) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Verfahren zur beschichtung einer oberfläche eines bauteils
EP2432531B1 (de) 2009-05-18 2019-03-06 Boehringer Ingelheim International GmbH Adapter, inhalationseinrichtung und zerstäuber
PT2435025T (pt) * 2009-05-29 2016-11-11 Pearl Therapeutics Inc Administração, por via respiratória, de agentes activos
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
WO2011027247A1 (en) 2009-09-03 2011-03-10 Sulur Subramaniam Vanangamudi An antifungal cream comprising terbinafine hydrochloride
GB0918149D0 (en) 2009-10-16 2009-12-02 Jagotec Ag Improved medicinal aerosol formulation
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
MX2012005961A (es) 2009-11-25 2012-06-14 Boehringer Ingelheim Int Nebulizador.
PT2467136E (pt) * 2009-12-07 2014-08-26 Raptor Therapeutics Inc Formulações de 4-metilpirazol
WO2011101830A1 (en) 2010-02-22 2011-08-25 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and clobetasone, and a process to make it
PH12012501666A1 (en) 2010-02-22 2012-11-05 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid - betamethasone dipropionate, and a process to make it
EP2585151B1 (en) 2010-06-24 2018-04-04 Boehringer Ingelheim International GmbH Nebulizer
WO2012017368A1 (en) 2010-08-02 2012-02-09 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, beclomethasone dipropionate and a process to make it
WO2012049543A1 (en) 2010-10-15 2012-04-19 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a corticosteroid, and a process to make it
WO2012130757A1 (de) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
KR102017915B1 (ko) * 2011-10-11 2019-09-03 키에시 파르마슈티시 엣스. 피. 에이. 지방산으로 코팅된 베타-작용제의 결정미세입자
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
JP6454323B2 (ja) 2013-03-15 2019-01-16 パール セラピューティクス，インコーポレイテッド 粒子状結晶性材料のコンディショニングのための方法及びシステム
JP6643231B2 (ja) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
EP2835146B1 (en) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Nebulizer
HUE058904T2 (hu) 2014-05-07 2022-09-28 Boehringer Ingelheim Int Porlasztókészülék
US10722666B2 (en) 2014-05-07 2020-07-28 Boehringer Ingelheim International Gmbh Nebulizer with axially movable and lockable container and indicator
CA2948071C (en) 2014-05-07 2022-08-30 Boehringer Ingelheim International Gmbh Container, nebulizer and use
US9360400B2 (en) 2014-06-30 2016-06-07 Proveris Scientific Corporation Sampling apparatus for determining the amount and uniformity of a delivered dose of drug and related methods
CN112472689B (zh) 2015-12-04 2023-01-17 墨西哥氟石股份公司 药物组合物
CA3016890A1 (en) 2016-03-09 2017-09-14 Proveris Scientific Corporation Methods for measuring dose content uniformity performance of inhaler and nasal devices
CN106619658B (zh) * 2016-12-28 2022-02-08 四川普锐特药业有限公司 一种医用气溶胶制剂及定量吸入气雾剂
WO2021219495A1 (en) 2020-04-28 2021-11-04 Dalcor Pharma Uk Ltd., Leatherhead, Zug Branch Methods for treating or preventing a viral infection or inhibiting viral replication
EP4228725A4 (en) 2020-10-15 2024-11-06 Proveris Scientific Corporation SYSTEMS AND METHODS FOR INHALATOR TESTING

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06511235A (ja) * 1991-06-10 1994-12-15 シェリング・コーポレーション クロロフルオロカーボン不含エアゾール製剤
JPH10510829A (ja) * 1994-12-22 1998-10-20 アストラ・アクチエボラーグ エアゾール製剤
JP2000503673A (ja) * 1996-08-29 2000-03-28 シェーリング コーポレイション クロロフルオロカーボンを含まないモメタゾンフロエートエーロゾルの処方物
WO2000051591A1 (en) * 1999-03-03 2000-09-08 Novartis Ag Combinations of formoterol and mometasone furoate for asthma
WO2000053187A1 (en) * 1999-03-09 2000-09-14 Astrazeneca Ab New combination of formoterol and mometasone in a pharmaceutical composition for treating respiratory disorders, such as asthma, rhinitis and copd
JP2000513340A (ja) * 1996-06-11 2000-10-10 ミネソタ マイニング アンド マニュファクチャリング カンパニー 医用ホルモテロールエアゾール製剤

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874063A (en) * 1991-04-11 1999-02-23 Astra Aktiebolag Pharmaceutical formulation
US6250300B1 (en) * 1992-12-11 2001-06-26 Ab Astra System for dispensing pharmaceutically active compounds
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
US6503537B2 (en) * 1997-03-20 2003-01-07 Schering Corporation Preparation of powder agglomerates
US6495167B2 (en) * 1997-03-20 2002-12-17 Schering Corporation Preparation of powder agglomerates
TW533865U (en) * 1997-06-10 2003-05-21 Glaxo Group Ltd Dispenser for dispensing medicament and actuation indicating device
EP1133301A1 (en) * 1998-11-26 2001-09-19 Britannia Pharmaceuticals Limited Anti-asthmatic combinations comprising surface active phospholipids
AR022695A1 (es) * 1999-01-28 2002-09-04 Schering Corp PORTADOR SoLIDO PARTICULADO Y MÉTODO PARA PROVEER CONTROL DE LA PARTICULADA PARA LA DISTRIBUCIoN DE TAMANO DE PARTíCULAS Y DE CONTENIDO AMORFO CONVERTIBLE DURANTE SU PREPARACION
US6156294A (en) * 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
BR0107764A (pt) * 2000-01-20 2002-11-12 Basilea Pharmaceutica Ag Composições de peptìdeo cìclico nasalmente administráveis
GB0009612D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic formulations
AU2001278115A1 (en) * 2000-08-04 2002-02-18 Longwood Pharmaceutical Research, Inc. Formulations of mometasone and a bronchodilator for pulmonary administration
TW200301698A (en) * 2001-12-21 2003-07-16 Bristol Myers Squibb Co Acridone inhibitors of IMPDH enzyme

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06511235A (ja) * 1991-06-10 1994-12-15 シェリング・コーポレーション クロロフルオロカーボン不含エアゾール製剤
JPH10510829A (ja) * 1994-12-22 1998-10-20 アストラ・アクチエボラーグ エアゾール製剤
JP2000513340A (ja) * 1996-06-11 2000-10-10 ミネソタ マイニング アンド マニュファクチャリング カンパニー 医用ホルモテロールエアゾール製剤
JP2000503673A (ja) * 1996-08-29 2000-03-28 シェーリング コーポレイション クロロフルオロカーボンを含まないモメタゾンフロエートエーロゾルの処方物
WO2000051591A1 (en) * 1999-03-03 2000-09-08 Novartis Ag Combinations of formoterol and mometasone furoate for asthma
WO2000053187A1 (en) * 1999-03-09 2000-09-14 Astrazeneca Ab New combination of formoterol and mometasone in a pharmaceutical composition for treating respiratory disorders, such as asthma, rhinitis and copd

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005536538A (ja) * 2002-08-23 2005-12-02 シェーリング　コーポレイション 薬学的組成物
JP2006312649A (ja) * 2002-08-23 2006-11-16 Schering Plough Corp 薬学的組成物
JP2010518076A (ja) * 2007-02-09 2010-05-27 シェーリング コーポレイション 安定な医薬エアロゾル製剤
JP2019503997A (ja) * 2015-12-04 2019-02-14 メキシケム フロー エセ・ア・デ・セ・ヴェ 薬学的組成物
JP2020073514A (ja) * 2015-12-04 2020-05-14 メキシケム フロー エセ・ア・デ・セ・ヴェ 薬学的組成物
JP6993335B2 (ja) 2015-12-04 2022-01-13 メキシケム フロー エセ・ア・デ・セ・ヴェ 薬学的組成物
JP6993398B2 (ja) 2015-12-04 2022-01-13 メキシケム フロー エセ・ア・デ・セ・ヴェ 薬学的組成物

Also Published As

Publication number Publication date
JP2010138184A (ja) 2010-06-24
CO5560551A2 (es) 2005-09-30
CN1649568A (zh) 2005-08-03
ES2361805T3 (es) 2011-06-22
BR0212089A (pt) 2004-08-03
HUP0401514A2 (hu) 2004-12-28
DE60239648D1 (de) 2011-05-12
PL368897A1 (en) 2005-04-04
JP2009185075A (ja) 2009-08-20
HK1128428A1 (en) 2009-10-30
NZ530987A (en) 2006-08-31
PE20030390A1 (es) 2003-04-24
EP1420759A2 (en) 2004-05-26
HK1151987A1 (en) 2012-02-17
ES2325316T3 (es) 2009-09-01
EP1420759B1 (en) 2009-05-06
US20050147565A1 (en) 2005-07-07
DE60232251D1 (de) 2009-06-18
CY1109212T1 (el) 2014-07-02
CN1649568B (zh) 2010-10-27
HK1060972A1 (en) 2004-09-03
KR100970531B1 (ko) 2010-07-16
SI1420759T1 (sl) 2009-10-31
ZA200401419B (en) 2005-01-26
US20030114428A1 (en) 2003-06-19
EP2092935B1 (en) 2011-03-30
MXPA04001875A (es) 2004-06-15
CA2457926A1 (en) 2003-03-13
AR036358A1 (es) 2004-09-01
AU2002313828B2 (en) 2005-09-08
CY1111726T1 (el) 2015-10-07
ES2389480T3 (es) 2012-10-26
DK2092935T3 (da) 2011-07-18
SI2092935T1 (sl) 2011-07-29
EP2092935A1 (en) 2009-08-26
WO2003020253A3 (en) 2003-05-22
EP2319494A1 (en) 2011-05-11
WO2003020253A2 (en) 2003-03-13
US20100143269A1 (en) 2010-06-10
ATE503461T1 (de) 2011-04-15
PT1420759E (pt) 2009-06-30
EP2319494B1 (en) 2012-06-13
ATE430555T1 (de) 2009-05-15
PL209640B1 (pl) 2011-09-30
CN101856362A (zh) 2010-10-13
HUP0401514A3 (en) 2012-08-28
KR20040031002A (ko) 2004-04-09
JP5170789B2 (ja) 2013-03-27
NO20041277L (no) 2004-03-26
DK1420759T3 (da) 2009-08-03
TWI324934B (en) 2010-05-21
PT2092935E (pt) 2011-05-31

Similar Documents

Publication Publication Date Title
JP5170789B2 (ja) 喘息治療用の製薬組成物
AU2002313828A1 (en) Pharmaceutical compositions for the treatment of asthma
US20100095963A1 (en) Pharmaceutical compositions
US20110182830A1 (en) Inhalation drug products, systems and uses
EP1785156B1 (en) Metered dose inhaler containing an aerosol suspension formulation
HK1128428B (en) Pharmaceutical compositions for the treatment of asthma
HK1151987B (en) Pharmaceutical compositions for the treatment of asthma
HK1060972B (en) Pharmaceutical compositions for the treatment of asthma
HK1103999A (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050706

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050719

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090226

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090526

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090821

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20091119

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20091127

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20091218

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20091228

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100120

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100127

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100420